Invited commentary:: Evidence-based evaluation of p values and Bayes factors

被引:26
作者
Katki, Hormuzd A. [1 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA
关键词
Bayes theorem; empirical research; epidemiologic methods; meta-analysis; observation; statistics;
D O I
10.1093/aje/kwn148
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Despite clear deficiencies of the p value as a summary of statistical evidence, compelling alternatives with strong theoretical justification, such as the Bayes factor and the related likelihood ratio, are rarely presented in epidemiologic publications. Comparison of the historical performance of the p value with that of its competitors in the epidemiologic literature may help epidemiologists evaluate whether Bayes factors or likelihood ratios lead to conclusions more quickly and reliably than a p value, given the same data. Empirical evidence presented by Ioannidis (Am J Epidemiol 2008; 168: 374-83) demonstrates that findings with p values near 0.05 tend not to be confirmed in future studies. Similarly, Bayes factors interpret p values near 0.05 as having, at best, promising evidence against the null hypothesis. However, the different types of Bayes factors require empirical evaluation of their performance in practice. P values remain popular because miniscule p values are unlikely to mislead and p values do not require alternative hypotheses. Publishing p values near 0.05 could be considered a low-threshold screen to allow many (possibly null) results to be published for follow-up consideration. Meta-analyses and studies meant to decisively convince skeptics require a stronger standard (p values much below 0.05) and a Bayes factor to interpret the p value and to facilitate incorporation of background expertise necessary for drawing comprehensive conclusions.
引用
收藏
页码:384 / 388
页数:5
相关论文
共 47 条
  • [1] Evaluating network-based missing protein prediction using p-values, Bayes Factors, and probabilities
    Goh, Wilson Wen Bin
    Kong, Weijia
    Wong, Limsoon
    JOURNAL OF BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, 2023, 21 (01)
  • [2] An Evaluation of the Evidence in "Evidence-Based" Integrative Medicine Programs
    Marcus, Donald M.
    McCullough, Laurence
    ACADEMIC MEDICINE, 2009, 84 (09) : 1229 - 1234
  • [3] Commentary: Risk Assessment in the Age of Evidence-Based Practice and Policy
    Desmarais, Sarah L.
    INTERNATIONAL JOURNAL OF FORENSIC MENTAL HEALTH, 2017, 16 (01) : 18 - 22
  • [4] How evidence-based is an 'evidence-based parenting program'? A PRISMA systematic review and meta-analysis of Triple P
    Philip Wilson
    Robert Rush
    Susan Hussey
    Christine Puckering
    Fiona Sim
    Clare S Allely
    Paul Doku
    Alex McConnachie
    Christopher Gillberg
    BMC Medicine, 10
  • [5] How evidence-based is an 'evidence-based parenting program'? A PRISMA systematic review and meta-analysis of Triple P
    Wilson, Philip
    Rush, Robert
    Hussey, Susan
    Puckering, Christine
    Sim, Fiona
    Allely, Clare S.
    Doku, Paul
    McConnachie, Alex
    Gillberg, Christopher
    BMC MEDICINE, 2012, 10
  • [6] Commentary: Sildenafil in Phallometric Testing-An Evidence-Based Assessment of Sexual Offenders
    Bradford, John M. W.
    Kingston, Drew
    Ahmed, A. G.
    Fedoroff, J. Paul
    JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW, 2010, 38 (04) : 512 - 515
  • [7] Evidence-Based Medicine: Principles and Values as Illustrated by the Case of Patient Blood Management
    Van Remoortel, Hans
    De Buck, Emmy
    Seifried, Erhard
    Vandekerckhove, Philippe
    HAMOSTASEOLOGIE, 2023, 43 (01): : 16 - 21
  • [8] HOW TO STRENGTHEN A CULTURE OF INNOVATION BY COMBINING VALUES-BASED AND EVIDENCE-BASED INNOVATION MANAGEMENT
    Seiler, Matthias
    Cott, Andreas B.
    Torres, Victor
    Reif, Julia A. M.
    Kugler, Katharina G.
    Gammel, Josef H.
    Brodbeck, Felix C.
    INTERNATIONAL JOURNAL OF INNOVATION MANAGEMENT, 2022, 26 (05)
  • [9] Evidence-Based Structuring and Evaluation of Empirical Research in Requirements Engineering
    Goeken, Matthias
    Patas, Janusch
    BUSINESS & INFORMATION SYSTEMS ENGINEERING, 2010, 2 (03) : 175 - 185
  • [10] Evidence-based evaluation of study results of symptomatic glucosamine therapy
    Reiter, S
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2005, 64 (07): : 456 - 466